Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-25-064324
Filing Date
2025-03-27
Accepted
2025-03-27 06:39:40
Documents
5
Effectiveness Date
2025-03-27

Document Format Files

Seq Description Document Type Size
1 S-8 d921736ds8.htm S-8 30102
2 EX-5.1 d921736dex51.htm EX-5.1 7040
3 EX-23.1 d921736dex231.htm EX-23.1 2100
4 EX-FILING FEES d921736dexfilingfees.htm EX-FILING FEES 21444
5 GRAPHIC g921736g10s57.jpg GRAPHIC 3234
  Complete submission text file 0001193125-25-064324.txt   66398
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Filer) CIK: 0001738021 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-286148 | Film No.: 25775158
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)